Flutivate Skin Cream is a prescription-strength topical corticosteroid formulated with fluticasone propionate 0.05% to calm inflamed, itchy skin. Clinically used for eczema, contact dermatitis, and limited plaque psoriasis, it reduces redness, swelling, and discomfort by suppressing inflammatory mediators in the skin. When applied as a thin film, it helps restore barrier comfort without the greasiness of heavier ointments. Appropriate, short, time-limited use under medical guidance supports symptom control while minimizing steroid-related risks. This overview explains how Flutivate works, who should and shouldn’t use it, safe application techniques, potential side effects, and U.S. access options so you can use it confidently.
Flutivate Skin Cream contains fluticasone propionate 0.05%, a medium-potency topical corticosteroid used to relieve inflammation and itching in steroid‑responsive skin conditions. Clinicians commonly recommend it for atopic dermatitis (eczema), allergic or irritant contact dermatitis (including reactions to metals, fragrances, or plants), lichen simplex chronicus (thickened, itchy patches), neurodermatitis, and small, localized areas of plaque psoriasis. By dampening inflammatory signals in the skin, it helps reduce redness, swelling, and the urge to scratch—supporting comfort and better sleep while the skin barrier recovers.
Flutivate is not an antifungal, antibiotic, or antiviral and should not be used alone on active skin infections. It is also not intended for acne, rosacea, perioral dermatitis, or routine cosmetic use. On sensitive sites like the face, groin, and underarms, use typically requires extra caution and shorter courses. Moisturizers remain the cornerstone of eczema care; Flutivate adds anti‑inflammatory control during flares.
Use the smallest amount that controls symptoms. For adults and adolescents, apply a thin film to the affected area once or twice daily as directed by your clinician. Many flare-ups respond within 3–7 days; therapy is typically limited to the shortest duration needed, often 1–2 weeks on the body and less on delicate areas. In children, courses are generally shorter; consult a pediatric clinician for age-appropriate guidance. Do not exceed the prescribed frequency or duration, and do not cover treated skin with occlusive dressings unless specifically instructed, as this can markedly increase absorption and side effects.
Application tips: cleanse hands and the affected skin gently, pat dry, then apply a thin layer using the fingertip unit method (one fingertip-length of cream roughly covers two adult palm areas). Allow the medication to absorb fully before applying an emollient; continue regular use of fragrance-free moisturizers several times daily to support the skin barrier. Avoid the eyes, mucous membranes, and broken skin. If irritation or worsening occurs, stop and seek medical advice.
Topical corticosteroids can cause local and, rarely, systemic side effects, especially when used on large surface areas, under occlusion, on thin skin, or for prolonged periods. Use the lowest effective potency and amount for the shortest time. Extra caution is advised on the face, neck, genitals, skin folds, and in children—who absorb proportionally more steroid through the skin. If there is any sign of infection (oozing, honey-colored crusts, spreading redness, pustules), seek guidance; often an antimicrobial is needed alongside, or the steroid is paused until infection is controlled.
During pregnancy and breastfeeding, use only if the potential benefit justifies the potential risk; avoid application to the nipple/areola before nursing. People with darker skin tones may be more prone to steroid-induced hypopigmentation; careful, short-term use helps reduce this risk. Do not use if the product appears discolored, contaminated, or past expiry. If you have glaucoma, cataracts, or eye surface disease, avoid application near the eyes and discuss alternatives. Report any unexpected skin changes promptly.
Do not use Flutivate Skin Cream if you have a known hypersensitivity to fluticasone propionate or any component of the formulation. It is contraindicated in untreated bacterial, fungal, or viral skin infections (including herpes simplex, varicella, and molluscum) without appropriate antimicrobial therapy. Avoid use in acne vulgaris, rosacea, and perioral dermatitis, where topical steroids can worsen disease. Do not apply to ulcerated skin, open wounds, or around the eyes.
If you have a history of steroid-induced skin atrophy, striae, or telangiectasia in the area you plan to treat, inform your clinician; a milder steroid or nonsteroidal option (such as calcineurin inhibitors for certain sites) may be preferable. In children and infants, use only under clinician supervision with age-appropriate potency and duration.
Most people tolerate fluticasone propionate well during short courses. Common, usually mild effects include transient burning, stinging, dryness, itching, or redness at the application site. With repeated or prolonged use—especially on thin skin, under occlusion, or at higher frequency—there is risk of skin atrophy (thinning), striae (stretch marks), telangiectasia (small visible vessels), easy bruising, folliculitis, acneiform eruptions, perioral dermatitis, and delayed wound healing. Hypo‑ or hyperpigmentation can occur, particularly in individuals with richly pigmented skin.
Systemic absorption is uncommon but possible, more so in young children or when treating large areas. Signs of excessive systemic steroid exposure may include fatigue, weight gain, facial puffiness, or elevated blood sugar; very rarely, hypothalamic–pituitary–adrenal (HPA) axis suppression may occur. Ocular complications (glaucoma, cataracts) have been reported with steroid exposure near the eyes. If severe irritation, skin infection, vision changes, or signs of steroid excess develop, stop the medication and seek medical care.
Because topical fluticasone has low systemic absorption when used appropriately, drug interactions are uncommon. However, if large areas are treated, if occlusion is used, or if therapy is prolonged, systemic exposure can increase. Strong CYP3A4 inhibitors (such as ritonavir, cobicistat, ketoconazole, itraconazole, and clarithromycin) may raise steroid levels and risk of systemic effects; caution and medical supervision are advised in these situations. Concurrent use of multiple potent topical steroids on the same area can compound local side effects.
On the skin, combining Flutivate with harsh exfoliants, alcohol-heavy toners, or irritant acne treatments can increase irritation; separate application times or use gentler skincare. If you need antifungal or antibiotic therapy for a secondary infection, your clinician may advise alternating or layering strategies—never mix products in the palm before applying unless specifically instructed.
If you miss a dose, apply it when you remember the same day. If it is close to your next scheduled application, skip the missed dose and resume your regular schedule. Do not double-apply or increase the quantity to “catch up,” as this raises the risk of local irritation and steroid side effects without improving outcomes.
If frequent missed doses are occurring, consider setting reminders and aligning application with daily routines (after morning and evening cleansing). Consistent moisturizer use between steroid applications often helps maintain symptom control with less need for medication.
Accidental acute overdose from a single excessive topical application is unlikely to cause harm beyond local irritation. The more important risk is chronic overuse—too much product, too often, for too long—which can lead to skin atrophy, striae, and, rarely, systemic corticosteroid effects such as HPA axis suppression. Children are more susceptible to systemic absorption.
If overuse is suspected, contact your clinician. Management typically includes gradually reducing frequency and amount, switching to a lower‑potency steroid, or transitioning to nonsteroidal anti‑inflammatories (e.g., tacrolimus or pimecrolimus) on sensitive areas. Treat secondary infections if present, and emphasize regular emollient skin care. Sudden cessation after very prolonged, heavy use should be guided by a clinician to avoid rebound flares.
Store Flutivate Skin Cream at room temperature as directed on the label, typically 20–25°C (68–77°F). Protect from excessive heat, direct sunlight, and freezing. Keep the cap tightly closed to prevent contamination and drying. Do not use if the seal is broken when first opened, or if the cream changes color, separates, or develops an unusual odor.
Keep out of reach of children and pets. Do not share prescription creams with others, even if their symptoms seem similar—skin conditions may look alike but require different treatments. Dispose of unused or expired medication according to local guidance or pharmacy take-back programs.
In the United States, fluticasone propionate cream (the active ingredient in Flutivate Skin Cream) is an Rx-only medication. Federal and state laws require a valid prescription, patient identity verification, and pharmacist oversight for dispensing. Buying prescription corticosteroids without a clinician’s authorization is not permitted. However, you do not need to arrive with a prewritten prescription: a legitimate telehealth evaluation can generate one when medically appropriate.
HealthSouth Rehabilitation Hospital of Las Vegas offers a legal, structured solution for acquiring Flutivate Skin Cream without prior paperwork by connecting you to licensed U.S. clinicians via telehealth. After a brief, secure medical intake and, when needed, a video consult, a prescriber reviews your history, confirms the indication, screens for red flags, and—if appropriate—issues a prescription that the pharmacy dispenses and ships. This compliant pathway maintains all regulatory safeguards, supports insurance or cash-pay options, and provides pharmacist counseling. Availability may vary by state; identity and age verification, as well as clinical appropriateness, are required. This service does not circumvent laws—it streamlines access while keeping you safe.
Flutivate Skin Cream contains fluticasone propionate 0.05%, a topical corticosteroid that calms overactive skin inflammation to reduce redness, swelling, and itch.
It is used for steroid‑responsive dermatoses such as eczema (atopic dermatitis), contact dermatitis, seborrheic dermatitis flares, lichen simplex, and body‑site psoriasis, as prescribed.
Clean and dry the area, apply a very thin film to affected skin only, gently rub in, avoid eyes and mucous membranes, and wash hands after application.
Most people use it 1–2 times daily for the shortest time needed; many courses last up to 1–2 weeks on the body unless your clinician advises otherwise.
These areas absorb more steroid and are prone to side effects; use only if directed, with very small amounts for very short periods, and keep away from the eyes.
It can be used when prescribed, typically with smaller amounts on limited areas for brief courses, with medical follow‑up to minimize growth and skin‑thinning risks.
Temporary burning or stinging may occur; with prolonged or excessive use, acneiform eruptions, skin thinning, stretch marks, visible vessels, discoloration, and rare adrenal suppression are possible.
Avoid occlusive dressings unless instructed, harsh exfoliants, applying to untreated infections, prolonged use on thin skin, and combining with other steroids without guidance.
No for untreated infections, and generally not for acne or rosacea, as steroids can worsen them; treat infections first and use appropriate acne/rosacea therapies.
Use only if clearly needed, on small areas for short periods. Avoid applying on the breast/nipple or wash off before feeding. Discuss risks and alternatives with your clinician.
It is not a bleaching agent, but improper or prolonged use can cause local hypopigmentation or uneven tone, particularly on darker skin.
Yes; apply a thin layer of Flutivate first, let it absorb for about 10–15 minutes, then moisturize. Separate from strong actives (like retinoids) to minimize irritation.
Apply when remembered unless close to the next dose. If used for a long time, taper frequency rather than stopping abruptly to reduce rebound flares.
Store capped at room temperature, away from heat and direct sunlight. Do not freeze. Keep out of reach of children and do not use past expiry.
If symptoms worsen or spread, signs of infection appear, severe irritation occurs, vision changes develop, or you need therapy beyond a couple of weeks, contact your clinician.
Use fingertip units: about one adult fingertip‑length covers two adult palm areas; adjust for child size and treat only affected skin.
Interactions are unlikely with limited use, but prolonged or large‑area application can increase absorption; tell your doctor if you take strong CYP3A4 inhibitors (e.g., ritonavir, cobicistat).
Flutivate (fluticasone 0.05%) is moderate‑potency and typically more effective for stubborn eczema or dermatitis than low‑potency hydrocortisone, but it also carries higher misuse risk.
Both are mid‑potency topical steroids; mometasone often works with once‑daily dosing and may be slightly stronger in some cases. Choice depends on site, age, and tolerability.
They are similar mid‑potency options; clinicians decide based on body site, vehicle preference, cost, and individual response rather than a large strength difference.
Betamethasone dipropionate is generally stronger; it’s often reserved for thick plaques, while Flutivate suits many inflamed areas needing a moderate approach.
Clobetasol is ultra‑potent for short bursts on very thick, resistant lesions; Flutivate is moderate potency and safer for larger areas or longer intervals when appropriate.
Both are mid‑potency; efficacy is often similar, with selection guided by site, vehicle, and patient tolerance.
Desonide is low‑potency and generally preferred for face, skin folds, and groin; Flutivate may be too strong for prolonged use in these areas.
Yes; ointments enhance penetration and suit very dry, thick plaques, while creams are less occlusive and suit moist or intertriginous areas. The same steroid can act stronger as an ointment.
Flutivate is usually stronger and better for moderate flares; low‑strength beclomethasone may be chosen for sensitive skin or maintenance.
Both reduce inflammation effectively; hydrocortisone butyrate is a mid‑potency ester with good penetration. Speed depends more on vehicle, site, and adherence than brand.
Halobetasol is ultra‑potent with higher atrophy and systemic risk if misused; Flutivate’s moderate potency is safer for larger areas and longer courses when needed.
Low‑dose fluocinolone is milder and often used for scalp or pediatric eczema; Flutivate is stronger and reserved for more inflamed lesions when a moderate steroid is warranted.